Cover Image

PROSPECTIVE SHORT TERM ANALYSIS OF FUNCTIONAL OUTCOME IN BENIGN BONE TUMOURS MANAGED WITH CURETTAGE AND ILIAC CREST AUTOGRAFT

SARAVANAN S K

Abstract


Benign bone tumours are commonly treated with curettage and bone grafting to eliminate the disease and to prevent pathological fractures. The aim of our research is to study the functional outcome in management of benign bone tumours with curettage and iliac crest bone graft. 15 patients with benign bone tumours managed with curettage and iliac crest bone grafting were prospectively analyzed from July 2014 to December 2015 in government general hospital, Chennai. The variables taken were age, sex, location of the tumour, type and stage of the tumour. Amount of bony   incorporation and period of bony union were assessed with serial x-rays and functional outcome were evaluated with Ennekings functional scoring. We found better bony             integration with giant cell tumour when compared to other benign tumours. Younger the age of the patient, better was the bony incorporation. More than 50 percentage of the  patients had excellent functional results as per Ennekings scoring. None of the patients had recurrence at 1 yr follow up. Thus we conclude that, in established bone tumours treated with curettage, iliac crest autograft is ideal to maintain the structural and functional continuity.

 


Full Text:

PDF

References


Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: efficacy and indications. J Am Acad Orthop Surg. LWW; 1995;3(1):1–8.

Mirra JM, Gold RH, Marcove RC. Bone Tumors, Diagnosis and Treatment: Diagnosis and Treatment. Lippincott Williams & Wilkins; 1980.

Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of Giant-Cell Tumors of Long Bones with Curettage and Bone-Grafting*. J Bone Jt Surg. The Journal of Bone and Joint Surgery, Inc.; 1999;81(6):811–20.

Banwart JC, Asher MA, Hassanein RS. Iliac crest bone graft harvest donor site morbidity: a statistical evaluation. Spine (Phila Pa 1976). LWW; 1995;20(9):1055–60.

Enneking WF. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. LWW; 1986;204:9–24.

Burwell RG. The function of bone marrow in the incorporation of a bone graft. Clin Orthop Relat Res. LWW; 1985;200:125–41.

Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, et al. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. LWW; 2002;397:248–58.

Suneja R, Grimer RJ, Belthur M, Jeys L, Carter SR, Tillman RM, et al. Chondroblastoma of bone LONG-TERM RESULTS AND FUNCTIONAL OUTCOME AFTER INTRALESIONAL CURETTAGE. J Bone Jt Surgery, Br Vol. British Editorial Society of Bone and Joint Surgery; 2005;87(7):974–8.

Burchardt H. The biology of bone graft repair. Clin Orthop Relat Res. LWW; 1983;174:28–34.

Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. Springer; 2008;134(9):969–78.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University